Rifapentine is active in vitro and in vivo against Toxoplasma gondii - Wikidata - awgldk - TriplyDB

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

http://www.wikidata.org/entity/Q28378988

about

Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis Two 2-hydroxy-3-alkyl-1,4-naphthoquinones with in vitro and in vivo activities against Toxoplasma gondii.The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection Intestinal parasite co-infection among pulmonary tuberculosis cases without human immunodeficiency virus infection in a rural county in China.Rifampin combination therapy for nonmycobacterial infections.

P2860

Q24550659-EDDB15A7-7199-4031-9607-8C3739F5441A Q26782581-4AB39A4E-06F5-44B3-85FD-F437A70039F0 Q28365205-9303F994-8A2D-47AB-8046-48FD10F45EB1 Q28368883-A044C924-256A-4193-9284-6AD4BE6D6266 Q28379168-1695F389-39A4-4881-AA27-CF107D7C5B63 Q37456038-BE3257B8-D753-4DF4-862A-7652D9BB285B Q37672039-E002D70A-4143-4093-A587-6341251122CE

P2860

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

http://www.wikidata.org/entity/Q28378988

description

1996 nî lūn-bûn

@nan

1996 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

@ast

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

@en

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

@nl

type

label

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

@ast

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

@en

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

@nl

prefLabel

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

@ast

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

@en

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

@nl

P1433

Q28378988-526756C1-D7BA-4C91-89F7-AA8F0B1A7396

P1476

Q28378988-9F527175-29FE-46D5-A004-B9156A7785AE

P2093

Q28378988-3CC5FE94-2234-4B9A-AB21-6A0AB9D722BA

Q28378988-63E4DA25-59A8-4405-90F1-8B1F38239469

Q28378988-BBA86D5C-B115-41E1-9046-FABFAC38350A

P2860

Q28378988-1F906F4F-241F-4BE1-BF5C-835B420C5349

Q28378988-27A97502-B7BA-4F2E-8884-5638B6BDE9EC

Q28378988-3BD8B82A-AA39-45D4-87A9-E2E5EF6D6B3A

Q28378988-46A77EE9-01F1-4AEC-85C7-3A603B71CA10

Q28378988-55EEDDA6-43A9-4DF2-9B13-31F97DED253F

Q28378988-5A517676-2428-42CF-87C6-67205CA095E3

Q28378988-841CD089-F55C-4516-9BDD-B08A9534BEB0

Q28378988-ABC0E7C1-A049-4FFB-89C2-8267CADC1616

Q28378988-D269E3F4-7768-40BE-9B1F-B7C49AF4CD79

P304

Q28378988-BB62C8A1-478E-4A66-925A-82B9AFBAD8A6

P31

Q28378988-193356CF-2E16-4300-8D41-031CB2D9C4B8

P356

Q28378988-1DA5CFA3-D896-48FF-B048-6141ECDC4E83

P407

Q28378988-1304B0C2-4471-47D7-ABFE-65E210A243A4

P433

Q28378988-C873CED4-C18C-4378-A82B-A28874711C08

P478

Q28378988-0315EB1E-E086-41AB-95BB-29AC07EBEC9F

P577

Q28378988-3522EC95-C1A5-4450-AFFF-998ADAB1FD8E

P698

Q28378988-AC9A7B74-2AC7-49D1-AB27-20278285DECA

P921

Q28378988-AB8D9F50-7B91-4F02-946A-6DC3D0A6301A

P932

Q28378988-2D7BEDB8-0F18-4997-8AA7-E946B99DD1EE

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Rifapentine is active in vitro and in vivo against Toxoplasma gondii

@en

P2093

A A Khan

http://www.w3.org/2001/XMLSchema#string

F G Araujo

http://www.w3.org/2001/XMLSchema#string

J S Remington

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Activity of rifapentine against Mycobacterium avium infection in beige mice

Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii

Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex

Rifabutin is active in murine models of toxoplasmosis

Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine

Toxoplasmic encephalitis in patients with AIDS.

New antibacterial drugs for the treatment of mycobacterial disease in man.

From the National Institutes of Health. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS.

P304

1335-1337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.40.6.1335

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

1996-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8725996

http://www.w3.org/2001/XMLSchema#string

P921

Toxoplasma gondii

P932

163326

http://www.w3.org/2001/XMLSchema#string